Microbial volatile communication in human organotypic lung models

Nature Communications

Volumn 8, Issue 1, 2017, Pages

  Barkal, Layla J ^a,b   Procknow, Clare L ^c   Álvarez Garciá, Yasmín R ^c   Niu, Mengyao ^c   Jiménez Torres, José A ^a,b   Brockman Schneider, Rebecca A ^d   Gern, James E ^d   Denlinger, Loren C ^d   Theberge, Ashleigh B ^e,f   Keller, Nancy P ^c   Berthier, Erwin ^e,g   Beebe, David J ^a,b  

^a Wisconsin Electric Machines and Power Electronics Consortium   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^g Tasso   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; VOLATILE AGENT; CYTOKINE; VOLATILE ORGANIC COMPOUND;

COLONIZATION; COMPLEXITY; FUNGUS; HOST-PATHOGEN INTERACTION; LABORATORY METHOD; MICROBIAL ACTIVITY; PATHOGEN; RESPIRATION; RESPIRATORY DISEASE;

AIRWAY; ARTICLE; ASPERGILLUS FUMIGATUS; BACTERIUM CULTURE; BRONCHIOLE; CONTROLLED STUDY; CYTOKINE RELEASE; EXTRACELLULAR MATRIX; FUNGUS CULTURE; FUNGUS SPORE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; INVASIVE ASPERGILLOSIS; LUNG INFECTION; LUNG MODEL; MICROBIAL COLONIZATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; ASPERGILLOSIS; BIOLOGICAL MODEL; CHEMISTRY; HOST PATHOGEN INTERACTION; IMMUNOLOGY; LUNG DISEASE; METABOLISM; MICROBIOLOGY; PSEUDOMONAS INFECTION;

ASPERGILLUS FUMIGATUS; PSEUDOMONAS AERUGINOSA;

ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BRONCHIOLES; CYTOKINES; HOST-PATHOGEN INTERACTIONS; HUMANS; LUNG DISEASES; MODELS, BIOLOGICAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; VOLATILE ORGANIC COMPOUNDS;

EID: 85034978443     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-017-01985-4     Document Type: Article

References (52)

1. Bulpa, P., Dive, A., Sibille, Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur. Respir. J. 30, 782-800 (2007).
2. World Health Organization. Global Surveillance, Prevention and Control of Chronic Respiratory Diseases: A Comprehensive Approach. (World Health Organization, Geneva, 2013).
3. Dickson, R. P., Huffnagle, G. B. The lung microbiome: New principles for respiratory bacteriology in health and disease. PLoS Pathog. 11, e1004923 (2015).
4. Man, W. H., de Steenhuijsen Piters, W. A. A., Bogaert, D. The microbiota of the respiratory tract: Gatekeeper to respiratory health. Nat. Rev. Microbiol. 15, 259-270 (2017).
5. BéruBé, K., Prytherch, Z., Job, C., Hughes, T. Human primary bronchial lung cell constructs: The new respiratory models. Toxicology 278, 311-318 (2010).
6. Huh, D., et al. Reconstituting organ-level lung functions on a chip. Science 328, 1662-1668 (2010).
7. Yamaya, M., Hosoda, M., Suzuki, T., Yamada, N., Sasaki, H. Human airway epithelial cell culture. Methods Mol. Biol. 188, 7-16 (2002).
8. Benam, K. H., et al. Small airway-on-a-chip enables analysis of human lung inflammation and drug responses in vitro. Nat. Methods 13, 151-157 (2016).
9. Briard, B., Heddergott, C., Latgé, J.-P. Volatile compounds emitted by pseudomonas aeruginosa stimulate growth of the fungal pathogen Aspergillus fumigatus. mBio 7, e00219 (2016).
10. Koo, S., et al. A breath fungal secondary metabolite signature to diagnose invasive aspergillosis. Clin. Infect. Dis. 59, 1733-1740 (2014).
11. Chambers, S. T., Bhandari, S., Scott-Thomas, A., Syhre, M. Novel diagnostics: Progress toward a breath test for invasive Aspergillus fumigatus. Med. Mycol. 49, S54-S61 (2011).
12. Ashraf, S., Brockman-Schneider, R., Gern, J. E. Propagation of rhinovirus-C strains in human airway epithelial cells differentiated at air-liquid interface. Methods Mol. Biol. 1221, 63-70 (2015).
13. Duffy, D. C., McDonald, J. C., Schueller, O. J., Whitesides, G. M. Rapid prototyping of microfluidic systems in poly(dimethylsiloxane). Anal. Chem. 70, 4974-4984 (1998).
14. Bischel, L. L., et al. The importance of being a lumen. FASEB J. 28, 4583-4590 (2014).
15. Jiménez-Torres, J. A., Peery, S. L., Sung, K. E., Beebe, D. J. LumeNEXT: A practical method to pattern luminal structures in ECM gels. Adv. Healthc. Mater. 5, 198-204 (2016).
16. Anderson, A. E., Foraker, A. G. Relative dimensions of bronchioles and parenchymal spaces in lungs from normal subjects and emphysematous patients. Am. J. Med. 32, 218-226 (1962).
17. Hansen, J. E., Ampaya, E. P. Human air space shapes, sizes, areas, and volumes. J. Appl. Physiol. 38, 990-995 (1975).
18. Tecle, T., Tripathi, S., Hartshorn, K. L. Review: Defensins and cathelicidins in lung immunity. Innate Immun. 16, 151-159 (2010).
19. Weitnauer, M., Mijošek, V., Dalpke, A. H. Control of local immunity by airway epithelial cells. Mucosal Immunol. 9, 287-298 (2016).
20. Jhingran, A., et al. Compartment-specific and sequential role of MyD88 and CARD9 in chemokine induction and innate defense during respiratory fungal infection. PLoS Pathog. 11, e1004589 (2015).
21. Struyf, S., et al. Synergistic induction of MCP-1 and-2 by IL-1beta and interferons in fibroblasts and epithelial cells. J. Leukoc. Biol. 63, 364-372 (1998).
22. Wright, W. R., et al. Cyclooxygenase and cytokine regulation in lung fibroblasts activated with viral versus bacterial pathogen associated molecular patterns. Prostaglandins Other Lipid Mediat. 107, 4-12 (2013).
23. Chiang, L. Y., Sheppard, D. C., Gravelat, F. N., Patterson, T. F., Filler, S. G. Aspergillus fumigatus stimulates leukocyte adhesion molecules and cytokine production by endothelial cells in vitro and during invasive pulmonary disease. Infect. Immun. 76, 3429-3438 (2008).
24. Bok, J. W., et al. LaeA, a regulator of morphogenetic fungal virulence factors. Eukaryotic Cell 4, 1574-1582 (2005).
25. Perrin, R. M., et al. Transcriptional regulation of chemical diversity in Aspergillus fumigatus by LaeA. PLoS Pathog. 3, e50 (2007).
26. Berthier, E., et al. Low-volume toolbox for the discovery of immunosuppressive fungal secondary metabolites. PLoS Pathog. 9, e1003289 (2013).
27. Dagenais, T. R. T., et al. Aspergillus fumigatus LaeA-mediated phagocytosis is associated with a decreased hydrophobin layer. Infect. Immun. 78, 823-829 (2010).
28. Knox, B. P., et al. Distinct innate immune phagocyte responses to Aspergillus fumigatus conidia and hyphae in zebrafish larvae. Eukaryotic Cell 13, 1266-1277 (2014).
29. Dagenais, T. R. T., Keller, N. P. Pathogenesis of Aspergillus fumigatus in Invasive Aspergillosis. Clin. Microbiol. Rev. 22, 447-465 (2009).
30. Carrion, S., de, J., et al. The RodA hydrophobin on Aspergillus fumigatus spores masks dectin-1-A nd dectin-2-dependent responses and enhances fungal survival in vivo. J. Immunol. 191, 2581-2588 (2013).
31. Driscoll, K. E. Macrophage inflammatory proteins: Biology and role in pulmonary inflammation. Exp. Lung Res. 20, 473-490 (1994).
32. Balloy, V., et al. Aspergillus fumigatus-induced interleukin-8 synthesis by respiratory epithelial cells is controlled by the phosphatidylinositol 3-kinase, p38 MAPK, and ERK1/2 pathways and not by the toll-like receptor-MyD88 pathway. J. Biol. Chem. 283, 30513-30521 (2008).
33. Mehrad, B., Moore, T. A., Standiford, T. J. Macrophage inflammatory protein-1 alpha is a critical mediator of host defense against invasive pulmonary aspergillosis in neutropenic hosts. J. Immunol. 165, 962-968 (2000).
34. Morton, C. O., Bouzani, M., Loeffler, J., Rogers, T. R. Direct interaction studies between Aspergillus fumigatus and human immune cells; what have we learned about pathogenicity and host immunity Front. Microbiol. 3, 413 (2012).
35. Kalleda, N., et al. Dynamic immune cell recruitment after murine pulmonary aspergillus fumigatus infection under different immunosuppressive regimens. Front. Microbiol. 7, 1107 (2016).
36. Caffrey, A. K., et al. IL-1 signaling is critical for leukocyte recruitment after pulmonary Aspergillus fumigatus challenge. PLoS Pathog. 11, e1004625 (2015).
37. Geiger, J., Wessels, D., Lockhart, S. R., Soll, D. R. Release of a potent polymorphonuclear leukocyte chemoattractant is regulated by white-opaque switching in Candida albicans. Infect. Immun. 72, 667-677 (2004).
38. Lim, F. Y., et al. Genome-based cluster deletion reveals an endocrocin biosynthetic pathway in Aspergillus fumigatus. Appl. Environ. Microbiol. 78, 4117-4125 (2012).
39. Shlezinger, N., et al. Sterilizing immunity in the lung relies on targeting fungal apoptosis-like programmed cell death. Science 357, 1037-1041 (2017).
40. Tyc, O., Zweers, H., de Boer, W., Garbeva, P. Volatiles in inter-specific bacterial interactions. Front. Microbiol. 6, 1412 (2015).
41. Spraker, J. E., et al. A volatile relationship: Profiling an inter-kingdom dialogue between two plant pathogens, Ralstonia solanacearum and Aspergillus flavus. J. Chem. Ecol. 40, 502-513 (2014).
42. Yin, G., et al. Effects of three volatile oxylipins on colony development in two species of fungi and on Drosophila larval metamorphosis. Curr. Microbiol. 71, 347-356 (2015).
43. Fischäder, G., Röder-Stolinski, C., Wichmann, G., Nieber, K., Lehmann, I. Release of MCP-1 and IL-8 from lung epithelial cells exposed to volatile organic compounds. Toxicology In Vitro 22, 359-366 (2008).
44. Pariselli, F., Sacco, M. G., Rembges, D. An optimized method for in vitro exposure of human derived lung cells to volatile chemicals. Exp. Toxicol. Pathol. 61, 33-39 (2009).
45. Amin, R., Dupuis, A., Aaron, S. D., Ratjen, F. The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis. Chest 137, 171-176 (2010).
46. Shirazi, F., Ferreira, J. A., Stevens, D. A., Clemons, K. V., Kontoviannis, D. P. Biofilm filtrates of Pseudomonas aeruginosa strains isolated from cystic fibrosis patients inhibit preformed Aspergillus fumigatus biofilms via apoptosis. PLoS ONE 11, e0150155 (2016).
47. Neerincx, A. H., et al. Identification of Pseudomonas aeruginosa and Aspergillus fumigatus mono-A nd co-cultures based on volatile biomarker combinations. J. Breath Res. 10, 016002 (2016).
48. Casavant, B. P., et al. Suspended microfluidics. Proc. Natl Acad. Sci. USA 110, 10111-10116 (2013).
49. Aghcheh, R. K., Druzhinina, I. S., Kubicek, C. P. The putative protein methyltransferase LAE1 of Trichoderma atroviride Is a key regulator of asexual development and mycoparasitism. PLoS ONE 8, e67144 (2013).
50. Pontecorvo, G., Roper, J. A., Forbes, E. Genetic recombination without sexual reproduction in Aspergillus niger. Microbiology 8, 198-210 (1953).
51. Guckenberger, D. J., de Groot, T. E., Wan, A. M., Beebe, D. J., Young, E. W. Micromilling: A method for ultra-rapid prototyping of plastic microfluidic devices. Lab Chip 15, 2364-2378 (2015).
52. Jaqaman, K., et al. Robust single-particle tracking in live-cell time-lapse sequences. Nat. Methods 5, 695-702 (2008).